Real World Evidence

Disease Network Delineates the Disease Progression Profile of Cardiovascular Diseases | 9/10/2020

As Electronic Health Records (EHR) data accumulated explosively in recent years, the tremendous amount of patient clinical data provided opportunities to discover real world evidence . In this study, a graphical disease network, named progressive cardiovascular disease network (progCDN), was built based on EHR data from 14.3 million patients to delineate the progression profiles of cardiovascular diseases (CVD). The network depicted the dominant diseases in CVD development, such as the heart …

[Webinar] Getting Started With Real World Evidence | 9/9/2020

Real world evidence (RWE) is becoming increasingly important for stakeholders as they make decisions across product lifecycles. IQVIA has made an on-demand webinar available to help you learn what RWE approaches are best for your business and where can you start. Topics of discussion include: Real world methodology How regulatory bodies use RWE for decision making, The role that RWE can play in speeding up access to medicines for …

Follow Real World Evidence:    

AI Applications for Clinical Trials Increase, Refining Endpoints, Quantifying Pain, & More | 9/7/2020

Artificial intelligence (AI) and machine learning (ML) are enabling clinical trial sponsors to fill in the gaps when real world evidence is incomplete or inconsistent. Trials suggest it can do even more, detecting early indicators of disease, and even quantifying pain. “Real world evidence (RWE) rarely has the same rigor as research data. RWE is collected through electronic health records (EHRs) as well as through clinical trials. Although agencies want …

Zen Garcia Vs. Globe Earth: The Key to Unlocking the True Cosmology | 9/7/2020

… up to new possibilities, like all are initially when forced to face the monumental truth that the earth cannot be spherical, as curvature is nonexistent. As I testified in court, when it comes to real world evidence , the actual process of determining the truth of this matter is as simple as conducting a curvature test and yet, so few were willing to do so, choosing to remain staunch supporters of …

Real World Evidence Market Factors Influencing the Growth of the Market | 9/7/2020

… and delays in drug development (and the subsequent increase in development costs). The base year considered for the study is 2017 and the forecast period includes 2018 to 2023. [157 Pages Report] The global real world evidence market is valued at 612.0 million in 2017 and projected to reach USD 1,348.1 million by 2023, at a CAGR of 14.3%. Objectives of the Study · To define, describe, and forecast the global …

Clinerion, Maxer Consulting partner to boost identification and recruitment of patients into clinical trials in Italy, promoting safer, more effective clinical outcomes | PRWeb | 9/3/2020

… trial sites and offering physicians more treatment options.” About Clinerion Clinerion accelerates clinical research and medical access to treatments for patients. We generate real-world data from our global network of partner hospitals for Real World Evidence analyses. Clinerion’s Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site feasibility evaluation and real-time patient search and identification to match …

Oncocyte and the Guardian Research Network® Announce Strategic Alliance NYSE:OCX | Globe Newswire | 9/3/2020

… company with a mission to provide actionable answers at critical decision points across the cancer care continuum, and the Guardian Research Network ® (GRN), a nationwide hospital consortium bringing access to cutting-edge trials and real world evidence clinical research to its community hospital members, today announced a strategic collaboration to create a comprehensive solution for pharma clients from patient recruitment to regulatory approvals. Oncocyte and GRN aim to leverage their …

Real World Evidence Market | | Major Factors Influencing the Growth of the Market | 9/3/2020

Real World Evidence Market Major Factors Influencing the Growth of the Market Posted on 2020-09-03 by MarketsandMarkets in Internet & Online // 0 Comments PUNE, India, 2020-Sep-03 — /EPR Network/ — [157 Pages Report] The global real world evidence market is valued at 612.0 million in 2017 and projected to reach USD 1,348.1 million by 2023, at a CAGR of 14.3%. The growth of this market is majorly driven by the rising …

Litmus Health Achieves HIPAA Compliance and NIST Cybersecurity Framework Adherence for Real World Data Infrastructure | PRWeb | 9/3/2020

… collection in the pharmaceutical industry, there has been increased demand for industry-wide data standards and established security protocols to ensure data integrity. Litmus serves customers interested in the collection, management, and analysis of real world evidence , improving clinical trial veracity by ensuring data collection is held to the highest standards. “Data standards and security are the foundation for all of our customer engagements. We’re excited to offer these review …

IRB Approved Observational CBD Safety Study is Now Underway | PRWeb | 9/2/2020

IRB Approved Observational CBD Safety Study is Now Underway Share Article ValidCare Virtual Study(TM) platform is capturing Real World Evidence on effects of CBD “ValidCare Study is a game changer for clinical research; especially in light of COVID-19. Now we can remotely recruit, screen, consent, monitor, and obtain intra-study feedback from participants in real time.” Keith Aqua, MD CENTENNIAL, Colo. ValidCare announced today that enrollment has been …

Aetion Adds Another $19M to its Series B to Make Sense of Drug Development and Treatment Data | 9/2/2020

Search Aetion Adds Another $19M to its Series B to Make Sense of Drug Development and Treatment Data SHARES In April, Aetion, the Real World Evidence Platform®, partnered with HealthVerity to launch a real-time treatment tracker for COVID-19, allowing doctors and researchers to assess outcomes and how treatments are evolving. A month later, Aetion partnered with the FDA to use real-world evidence to analyze potential treatment plans …

CannaCraft’s Care By Design Hemp to Participate in Industry Leading Study on CBD Safety | PR Newswire | 9/2/2020

SANTA ROSA, Calif. , Sept. 2, Care By Design Hemp , a wholly-owned CannaCraft brand, announced today that it joined several industry leaders in an IRB-approved study to provide real world evidence of safety in cannabinoid product use which commenced this month. The ValidCare study will measure the effects on the liver from daily use of full spectrum hemp derived CBD and CBD isolate by healthy adults. The resulting third …

Medical Affairs Executive Director, National Accounts Federal, and Select Supply & Care Delivery (Remote) : Los Angeles | 9/1/2020

… seeking to improve patient outcomes and customer experience. In addition, they will identify opportunities to advance the care continuum and the delivery of healthcare through broad clinical and population health research opportunities that include Real World Evidence (RWE) and the ability to leverage the suite of Roche assets across Flatiron Health, Foundation Medicine, and Roche Diagnostics as appropriate. The Medical Affairs Executive Director, National Accounts Federal, and Select Supply & Care …

Andy Corts Joins SignalPath Executive Team to Lead Research Strategy | Financial Buzz | 9/1/2020

… science industries. Most recently, Corts was the Chief Information Officer at Sarah Cannon, the Cancer Institute of HCA Healthcare. In that role, he led the development of their clinical trial platform, personalized medicine and real world evidence offerings as well as their care management program. “We are thrilled to have Andy join our executive team as we continue to develop innovative solutions that allow us to reimagine trial execution across …

Project Manager_Scientific I (Assistant) | 8/31/2020

… and you have to stay in 1 spot and distanced. This job is operational and the candidate will not be contributing scientifically to the studies. Under the broad guidance of the Center for Observational & Real World Evidence (CORE) Director of Operations the primary responsibilities/skills for this position include and are not limited to the following: Functioning & long term strategy planning of the CORE document review committee (DRC) which includes …

Vice-President Real World Evidence and Genomics - Telecommute - UnitedHealth Group - CA, CA | 8/28/2020

Business acumen Stakeholder socialization/partner networking You’ll enjoy the flexibility to telecommute from anywhere within the U.S. as you take on some tough challenges. Primary Responsibilities: Have direct responsibility for the oversight, hands on participation and delivery of large scale data projects/programs. Large scale programs are defined as high cost, high complexity, high risk, and/or a designated client portfolio. Help set scientific/operational strategy for Optum’s ClinicoGenomics research …

Digital Patient Monitoring and Real World Evidence Platform Launched | 8/27/2020

Self Care Catalysts has recently launched a patient-focused digital health platform. It allows patients to share their symptoms with their healthcare providers so they can receive personalized treatment. Toronto, Canada - August 27, 2020 / PressCable / — Self-Care Catalysts have recently launched COVID tools within its Health Storylines, a digital therapeutics platform that allows healthcare providers to monitor patients who have been affected by the pandemic through their shared experiences. For …

Pharmaceutical and Life Sciences Real World Evidence: Mark… | Flickr | 8/26/2020

The process of developing new and disruptive medical products involves heavy investments, both in terms of time and cost. Estimates suggest that each prescription drug requires an average of about 10 years and over USD 2.5 billion in working capital before it gets commercialized. In order to gain regulatory approval and establish standards. - www.rootsanalysis.com/reports/view_document/pharmaceutica …

Real World Evidence Poised to Tip the Balance in Fight Against COVID-19 Through Aetion’s Series B Platform | 8/26/2020

Featured / Real World Evidence Poised to Tip the Balance in Fight Against COVID-19 Through Aetion’s Series B Platform Real World Evidence Poised to Tip the Balance in Fight Against COVID-19 Through Aetion’s Series B Platform Tech startup Aetion has added US$19 million to their real-world evidence platform Series B, bringing their round to US$82 million. Aetion believes Series B can give an earlier and more …

MINDACT Study Shows MammaPrint® Provides Widespread Health System Cost Savings | PR Newswire | 8/25/2020

… their physicians the information they need to make the best decisions for the full treatment journey. The company currently offers two commercially-available genomic profiling tests, supported by the highest levels of clinical and real world evidence , that provide comprehensive genomic information that can be used to identify the most effective breast cancer treatment possible for each patient. MammaPrint®, the 70-gene breast cancer recurrence assay, is the only FDA …

Trialbee Partners with Clinerion for Expanded Access to Global Real-World Data to Accelerate Patient Recruitment for Clinical Trials | PRWeb | 8/25/2020

… accelerate the introduction of new medicines and interventions.” About Clinerion Clinerion accelerates clinical research and medical access to treatments for patients. We generate real-world data from our global network of partner hospitals for Real World Evidence analyses. Clinerion’s Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site feasibility evaluation and real-time patient search and identification to match …

Global Medical Device CROs Market 2020-2030 - Total Revenues from Global Sales of Medical Devices is Likely to Be Around US$ 450 Billion in 2020 | PR Newswire | 8/20/2020

… 16.1. Chapter Overview 16.2. Anticipated Growth in Number of Connected Devices 16.3. Adoption of Data Analytics and Real-Time Monitoring Solutions 16.4. Need for Cloud-based Computing and Storage Solutions 16.5. Growing Need for Real World Evidence for Regulatory Approval 16.6. Concluding Remarks 17. INTERVIEW TRANSCRIPTS 17.1. Chapter Overview 17.2. Lajos Sarosi , Chief Executive Officer and Co-founder, HungaroTrial 17.3. Troy McCall , Chief Operating Officer, CROMSOURCE 17.4. Christian Wolflehner, Managing …

Real World Evidence Market | North America to Dominate the Market | 8/20/2020

Home Biotechnology Real World Evidence Market North America to Dominate the Market Real World Evidence Market North America to Dominate the Market Aug 20th, Real World Evidence Market North America to Dominate the Market Real-world evidence is the clinical evidence regarding the usage and potential benefits or risks of a medical product derived from the analysis of real-world data. Real-world data (RWD) is defined as data derived …

[Presentation] IMPACCT: Real World Evidence–Use of Real World Data Outside of Traditional Comparative Effectiveness Research | 8/20/2020

Presentation] IMPACCT: Real World Evidence–Use of Real World Data Outside of Traditional Comparative Effectiveness Research [Presentation] IMPACCT: Real World Evidence–Use of Real World Data Outside of Traditional Comparative Effectiveness Research [Presentation] IMPACCT: Real World Evidence–Use of Real World Data Outside of Traditional Comparative Effectiveness Research by Ravi Iyer, Director GHEOR, TEVA Pharmaceuticals Inc …

[Presentation] IMPACCT: Real World Evidence–The Rile of Real World Evidence (RWE) in a Comprehensive Product Evidence Generation Plan | 8/20/2020

Industry News / [Presentation] IMPACCT: Real World Evidence–The Rile of Real World Evidence (RWE) in a Comprehensive Product Evidence Generation Plan [Presentation] IMPACCT: Real World Evidence–The Rile of Real World Evidence (RWE) in a Comprehensive Product Evidence Generation Plan [Presentation] IMPACCT: Real World Evidence–The Rile of Real World Evidence (RWE) in a Comprehensive Product Evidence Generation Plan by Cathy W Critchlow, PHD Centre For Observational Research, Amgen, Inc …

Electronic Health Records

National Evaluation System for health Technology Coordinating Center Announces First International Research Network Collaborator | Business Wire | 7/20/2020

… the Medical Device Innovation Consortium ( MDIC ), today announced NorthWest EHealth ( NWEH ) and Discover-NOW , the Health Data Research Hub for Real World Evidence, as its newest Network Collaborator partnership and first international addition to its … hospitals/medical centers. NESTcc Network Collaborators also have access to electronic health records (EHR), pharmacy data, public and private claims, registry data, patient-generated data, unique device identifiers (UDI), and supplemental data, including billing, supply …

Clinical Research

National Evaluation System for health Technology Coordinating Center Announces Launch of NEST 1.0 | Business & Finance | heraldchronicle.com | Business Wire | 6/30/2020

… evidence is needed to inform clinical decision-making and keep patients safe,” said Adrian Hernandez, M.D., MHS, professor of Medicine at Duke School of Medicine, vice dean and executive director of the Duke Clinical Research Institute, and chair of the NESTcc Governing Committee. “NESTcc is at the forefront driving transformative and scientifically sound research, and the ecosystem stands to benefit from the evidence resulting from NESTcc’s growth.” NESTcc enables the …

Medical Innovation

National Evaluation System for health Technology Coordinating Center Announces Launch of NEST 1.0 | Business & Finance | heraldchronicle.com | Business Wire | 6/30/2020

ARLINGTON, Va.–(BUSINESS WIRE)–Jun 30, 2020– The National Evaluation System for health Technology Coordinating Center ( NESTcc ), an initiative of the Medical Device Innovation Consortium ( MDIC ), today announced that it has officially opened for the management of sponsor-funded research projects to advance the use of real-world data (RWD) in medical device evaluation. The public launch of NEST 1.0 is a key inflection point in the maturity of NESTcc …

EMR

Real world evidence on 5661 patients treated for macular oedema secondary to branch retinal vein occlusion with intravitreal anti-vascular endothelial growth factor, intravitreal dexamethasone or macular laser | BMJ | 6/12/2020

PDF Clinical science Real world evidence on 5661 patients treated for macular oedema secondary to branch retinal vein occlusion with intravitreal anti-vascular endothelial growth factor, intravitreal dexamethasone or macular laser on behalf of UK EMR Users Group 1 Ophthalmology , Hightown Surgery , York , UK 2 York Teaching Hospital NHS Foundation Trust , York , North Yorkshire , UK 3 Institute of Health Informatics , University College London , London , London , UK 4 Department of Ophthalmology …

Digital Health

NCCN Policy Summit Explores 21st Century Cures Act and the Impact of Health Information Technology | PR Newswire | 6/10/2020

… of Food and Drugs , The Food and Drug Administration (FDA) held a fireside chat on clinical trials, data, and how real world evidence is changing the research landscape. Don Rucker , MD, MBA, MS , National Coordinator … Comprehensive Cancer Center and Clinical Informatics Lead , UCSF Center for Digital Health Innovation; and Susan Stiles , MHA, MBA, FACHE , Executive, Oncology Business Unit , Cerner Corporation. “Today, it takes an extraordinary effort for patients to access …

Food and Drug Administration

NCCN Policy Summit Explores 21st Century Cures Act and the Impact of Health Information Technology | Yahoo News | 6/10/2020

Food and Drug Administration (FDA) held a fireside chat on clinical trials, data, and how real world evidence is changing the research landscape. Don Rucker , MD, MBA, MS , National Coordinator for Health Information Technology , Office of the National Coordinator for Health IT (ONC) spoke about increasing the use of electronic medical records. NCCN Logo (C)NCCN(R) 2018. All rights reserved. Más “The Office of the National Coordinator for Health …

COVID-19

Real World Evidence Analytics is Turning Out to be a ‘Life Saver’ in Healthcare | Quantzig’s Recent Article Offers Unprecedented Insights on Its Benefits | Business Wire | 5/4/2020

… analytics solutions to resolve complex business problems has announced the completion of its latest article that analyzes the role of real world evidence analytics in driving better healthcare outcomes . This press release features multimedia. View … to complement the knowledge gained from traditional clinical trials. As COVID-19 spreads across geographies, our analytics experts suggest that there is no greater need to emphasize on the benefits of real-world evidence analytics …

CDC

Hackensack Meridian Health Develops RE-COV-RY (Real world Evidence - COVid-RegistrY) to Study the Effects of COVID-19 and Releases Key Findings on Hypertension and ACE/ARB Treatments | PR Newswire | 4/25/2020

… prior to publication in peer-reviewed journals. The study was based on a ground-breaking database – the RE-COV-RY (Real world Evidence-COVid-RegistrY) – one of the largest compilations of hospital-based COVID-19 … the risk of heart disease, stroke and kidney failure. The CDC has reported that nearly three in four hospitalized COVID-19 patients 65 and older had hypertension. A major debate is underway on why hypertension …

Biotechnology Innovation Organization

Scientist.com and HealthEconomics.Com Partner to Enable Online Sourcing of Health Economics and Outcomes Research (HEOR) and Real World Evidence (RWE) | Business Wire | 4/9/2020

Scientist.com and HealthEconomics.Com Partner to Enable Online Sourcing of Health Economics and Outcomes Research (HEOR) and Real World Evidence (RWE) The HEOR & RWE Marketplace connects buyers and sellers of HEOR and RWE April 09, 2020 … marketplaces for most of the world’s major pharmaceutical companies, the Biotechnology Innovation Organization (BIO) and the US National Institutes of Health (NIH). Since its founding in 2007, Scientist.com has raised $39 million from 5AM Ventures …

Medicaid

Avalere Health Partners With Leading Registry And Analytics Company, Corrona LLC, To Combine Economic And Clinical Outcomes Data For Autoimmune Diseases | PR Newswire | 3/17/2020

… data on more than 314 million unique patients spanning 53 billion medical events and more than 988,000 physicians across Medicare, Medicaid, and commercially insured markets. Corrona collects deep clinical data on validated physician assessments used … being of patients with autoimmune diseases.” About Corrona Corrona provides real world evidence through syndicated registry data and analysis services, helping biopharmaceutical companies demonstrate the value of their products to clinicians, patients, payers, and regulators …

Clinical Data

Anavex Life Sciences Presents ANAVEX®2-73 (blarcamesine) Data at 12th Clinical Trials on Alzheimer’s Disease (CTAD) 2019 Conference Nasdaq:AVXL | Globe Newswire | 12/4/2019

… 104-Week) Timepoint Abundance of Lachnospiraceae and Enterobacteriaceae Families as Potential Biomarker of Response from a 2-Year Study Interim Clinical Data Analysis of ANAVEX ® 2-73 ( blarcamesine ) NEW YORK, Dec. 04, 2019 (GLOBE NEWSWIRE) – Anavex … to improved response with ANAVEX®2-73 ( blarcamesine ).” FDA’s Framework for Real World Evidence document released in December 2018 demonstrates how Real World Evidence can be incorporated into regulatory decision-making. This framework was applied to …

HIPAA

VeraSci’s Innovation Lab Launches Wearable Technology Validation Study | PR Newswire | 12/4/2019

HIPAA and FDA-Part 11 regulations. Dr. Luca Pani , VeraSci VP for Regulatory Strategy and Market Access Innovation, and former Director General of the Italian Medicines Agency commented, “The potential for greater integration of wearables in CNS trials to collect high quality real world evidence (RWE) before, during and after product approval is enormous. To be truly informative, however, endpoints collected by these devices must undergo the same clinical and …

Clinical Trials Data

COTA Presents Posters at ASH Annual Meeting, Reviewing Complexities of Generating RWD and How it Complements Traditional Clinical Trial Data | PR Newswire | 12/4/2019

BOSTON , Dec. 4, COTA, Inc., a healthcare technology company that uses real-world data (RWD) to bring clarity to cancer care, is presenting posters at the American Society of Hematology Annual Meeting & Exposition, ASH 2019, in Orlando, FL from December 7-10, 2019 . Collectively, the posters review existing challenges for generating RWD and the promise of this data to support new research in cancer biology. “The genetic environment – whether of individual …

Patient ID

Clinerion and Massive Bio partner to improve cancer patient lives | PRWeb | 12/3/2019

… screening and inclusion in trials, speeding up patient recruitment. Massive Bio provides end-to-end patient enrollment technology and services in oncology clinical trials for patients treated at community practices. These services include patient identification/engagement, pre-screening, JIT site activation, and real-world data services. Massive Bio structures medical records, NGS results and clinical trials with its proprietary ontologies and Natural Language Processing (NLP) technology. Massive Bio has also …

Patient Networks

Clinerion and Massive Bio partner to improve cancer patient lives | PRWeb | 12/3/2019

Clinerion and Massive Bio partner to improve cancer patient lives Share Article Clinerion, provider of the Patient Network Explorer platform which harnesses patient data from a global hospital network, and Massive Bio, provider of end-to-end patient enrollment services for oncology, partner to improve trial site selection and thereby offer better access for cancer patients to leading-edge clinical trials. BASEL, Switzerland Clinerion offers Massive Bio access to oncology …

Clinical Trial Recruitment

Clinerion and Massive Bio partner to improve cancer patient lives | PRWeb | 12/3/2019

… medical access to treatments for patients. We use proprietary technologies for analysis of patient data from our global network of partner hospitals. Clinerion’s Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site feasibility evaluation and real-time patient search and identification to match patients to treatments. Our technology solution provides real-world evidence analytics for medical access. Clinerion facilitates …

Patient Recruitment

Clinerion and Massive Bio partner to improve cancer patient lives | PRWeb | 12/3/2019

… better access for cancer patients to leading-edge clinical trials. BASEL, Switzerland Clinerion offers Massive Bio access to oncology patient insights for site outreach and identification of cohorts for trial site selection and patient recruitment. Clinerion’s Patient Network Explorer queries anonymized patient data from its international network of partner hospitals to deliver real-world health data insights useful for Massive Bio’s site outreach programs. Clinerion’s ANID technology meanwhile allows authorized …

Patient Identification

Clinerion and Massive Bio partner to improve cancer patient lives | PRWeb | 12/3/2019

… screening and inclusion in trials, speeding up patient recruitment. Massive Bio provides end-to-end patient enrollment technology and services in oncology clinical trials for patients treated at community practices. These services include patient identification/engagement, pre-screening, JIT site activation, and real-world data services. Massive Bio structures medical records, NGS results and clinical trials with its proprietary ontologies and Natural Language Processing (NLP) technology. Massive Bio has also …

Precision Medicine

TriNetX Expands into South Korea in Partnership with EvidNet | PR Newswire | 12/3/2019

… data research and improve the quality of medical treatment. EvidNet is revolutionizing the way of healthcare data innovation through generation of evidence from a fully integrated data network, ultimately pioneering new paradigms in precision medicine and efficient healthcare systems. For more information, visit EvidNet at www.evidnet.com . Media Contacts …

Medical Imaging

The three hurdles facing your RWE efforts and how to get over them | 12/2/2019

By Matthew Michela There are three big hurdles in the way of effective use of Real World Evidence (RWE). Each of them is more complex, harder to deal with and takes longer to implement than most people think. Fortunately, solutions for each one of these issues are also closer to being available than most people realize. 901678 Times Visited: 7864 THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE …

Virtual Care

Onduo Publishes Real-world Evidence Demonstrating Significant Improvement in Glycemic Control for Program Participants With Type 2 Diabetes | Business & Finance | heraldchronicle.com | Business Wire | 12/2/2019

… of 2.3%, from 10.7% to 8.3% (p 0.001). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191202005534/en/ Onduo (Graphic: Business Wire) Onduo operates a smartphone-based virtual care program for people with type 2 diabetes that offers remote lifestyle coaching from certified diabetes educators and health coaches, connected tools and devices, and access to clinical support from board-certified endocrinologists via a virtual …

Diagnostic Imaging

Virtual Press Office Exhibitor Profiles: RSNA 2019 – Company Announcement - FT.com | Financial Times | 11/25/2019

… NJ , is the U.S.-based subsidiary of Bracco Imaging SpA. BDI offers a product and solution portfolio for all key diagnostic imaging modalities: X-ray Imaging (including Computed Tomography-CT, Interventional Radiology, and Cardiac Catheterization … in life sciences & medical data analytics. Medexprim is your unique Real World Evidence - Real Word Data partner. MXR Imaging Booth 7558 Press Kit: rsna.vporoom.com/MXRImaging MXR Imaging – The Imaging Solution Company (MXR) is the largest …

Patient Centricity

(USA-IL-Northbrook) Executive Director Patient Insights, Solutions & Outcomes | 11/23/2019

Patient Centricity will be accountable for managing a global team as well as oversight for all outputs. This group will focus on patient driven solutions based on the real-world conditions of patients with a particular emphasis on behavioral science, digital/technology use and utilization of Real World Evidence (RWE). This individual will require excellent leadership, communication and organizational skills. The position will also require extensive understanding of patients in …

Mental Health

Arabkir Joint Medical Center & Institute of Child and Adolescent Health joins Patient Network Explorer, expanding Clinerion’s global hospital network to Armenia | PRWeb | 11/21/2019

… Center & Institute of Child and Adolescent Health, in Yerevan, Armenia, has a wide specialization, which includes services for allergology, dermatovenereology, pediatric gastroenterology and hepatology, pediatric rheumatology, trauma and orthopedics, endocrinology and diabetes, pulmonology, mental health, pediatric gynecology, and neurology and epileptology, among others. The hospital has departments for hemodialysis and kidney transplantation, anesthesiology and intensive therapy, uro-surgery, ENT/otorhinolaryngology and plastic surgery, nephrology, and intensive care and resuscitation. Patient …

Readmissions

Highmark Health’s VITAL Innovation Platform is testing the benefits of Moving Analytics’ virtual cardiac rehabilitation program | PR Newswire | 11/20/2019

… co-founder, Moving Analytics, “VITAL provides us with a robust, integrated claims and clinical environment upon which we can further demonstrate MOVN’s ability to deliver an outstanding experience to patients while achieving fewer readmissions, better prevention of recurrent cardiac episodes and lower health care costs.” 1,3 Home-Based Cardiac Rehabilitation, AACVPR/AHA/ACC Scientific Statement, Randal J. Thomas , MD, MAACVPR, FAHA,FACC, Chair, et.al., Circulation, October 9, 2019 , e69-e89 …

Clinerion

Trialbee Partners with Clinerion for Expanded Access to Global Real-World Data to Accelerate Patient Recruitment for Clinical Trials | PRWeb | 8/25/2020

Trialbee Partners with Clinerion for Expanded Access to Global Real-World Data to Accelerate Patient Recruitment for Clinical Trials Share Article Trialbee, a leading global technology provider for patient matching and engagement in clinical trials … world data from our global network of partner hospitals for Real World Evidence analyses. Clinerion’s Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site …

Quantzig

Market Tracking and Real World Drug Performance Analysis Helps a Pharmaceutical Firm Increase Market Share | Get in Touch to Learn More About Quantzig’s Real World Evidence Analytics Capabilities | Business Wire | 8/12/2020

LONDON–(BUSINESS WIRE)–Aug 12, 2020– Premier analytics service provider, Quantzig announces the completion of its real world evidence analytics engagement . The success story offers comprehensive insights into how they helped a leading pharma company to analyze future growth opportunities and track market shares based on the performance of two newly launched oral oncolytic drugs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200812005314 …

McKesson

Evidation Raises $45 Million Series D, Hires CCO To Accelerate Commercial Momentum and Expand Into Virtual Health | Business Wire | 7/1/2020

… build upon its existing evidence generation capabilities to offer real-time insights and digital tools to its network of nearly 4 million individuals. B Capital Group led the round, which includes new investors McKesson Ventures and Section 32 as well as existing investors Revelation Partners, Rethink Impact, and SV Health Investors. B Capital’s Adam Seabrook has joined Evidation’s Board of Directors. Sam Marwaha, Senior Partner at Boston Consulting Group and …

Celgene

Industry Luminaries Across Biopharmaceuticals, Payers, and Technology Convene on GNS Healthcare’s In Silico Patient Advisory Board | PR Newswire | 4/21/2020

… Advisory Board are: Michael Bonney – Executive Chairman of Kaleido Biosciences and board member of BMS and Alnylam, former CEO of Cubist Tom Daniel - Venture Partner at ARCH, former President of R&D at Celgene Peter Neupert - Lead Director at Adaptive and LabCorp, former Corporate Vice President at Microsoft and Founder/CEO of drugstore.com Lee Newcomer - former Senior Vice President, Oncology and Genetics, and Chief Medical Officer at UnitedHealth Group “We …

Saama Technologies

Leading Life Sciences and Information Technology Companies Join EndPandemic National Data Consortium to Integrate COVID-19 Clinical Data - Business Wire | 4/14/2020

… EndPandemic National Data Consortium partners are to be applauded for the speed with which they answered the call to protect and ensure public health,” said Kenneth Massey, Pharm.D., Chief Life Sciences Officer of Saama Technologies. “The integrated database developed by the Consortium will be a comprehensive, collective platform that will inform and accelerate medical experts’ abilities to arrive at actionable decisions in relation to COVID-19 clinical research.” The EndPandemic …

IQVIA

The Global Real World Evidence Solution Market is expected to grow from USD 849.89 Million in 2019 to USD 1,785.13 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 13.16% | PR Newswire | 4/13/2020

PRNewswire/ – Real World Evidence Solution Market Research Report by Component (Claims Data, Clinical Settings Data, Patient-powered Data, Pharmacy Data, and Services), by Therapeutic Area (Cardiovascular Disease, Immunology, Neurology, and Oncology), by End-User - Global … Clinigen Group plc, Cognizant, HealthiVibe, LLC, IBM Corporation, ICON plc, IQVIA, Mercy Technology Services, Oracle Corporation, PAREXEL International Corporation, Pharmaceutical Product Development, LLC, SAS Institute Inc., Syneos Health, Tornado Sistems SRL, and Turacoz. FPNV Positioning …

Parexel

The Global Real World Evidence Solution Market is expected to grow from USD 849.89 Million in 2019 to USD 1,785.13 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 13.16% | PR Newswire | 4/13/2020

PRNewswire/ – Real World Evidence Solution Market Research Report by Component (Claims Data, Clinical Settings Data, Patient-powered Data, Pharmacy Data, and Services), by Therapeutic Area (Cardiovascular Disease, Immunology, Neurology, and Oncology), by End-User - Global … IBM Corporation, ICON plc, IQVIA, Mercy Technology Services, Oracle Corporation, PAREXEL International Corporation, Pharmaceutical Product Development, LLC, SAS Institute Inc., Syneos Health, Tornado Sistems SRL, and Turacoz. FPNV Positioning Matrix:The FPNV Positioning Matrix evaluates …

Syneos Health

The Global Real World Evidence Solution Market is expected to grow from USD 849.89 Million in 2019 to USD 1,785.13 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 13.16% | PR Newswire | 4/13/2020

PRNewswire/ – Real World Evidence Solution Market Research Report by Component (Claims Data, Clinical Settings Data, Patient-powered Data, Pharmacy Data, and Services), by Therapeutic Area (Cardiovascular Disease, Immunology, Neurology, and Oncology), by End-User - Global … PAREXEL International Corporation, Pharmaceutical Product Development, LLC, SAS Institute Inc., Syneos Health, Tornado Sistems SRL, and Turacoz. FPNV Positioning Matrix:The FPNV Positioning Matrix evaluates and categorizes the vendors in the Real World Evidence Solution …

Allergan

China Gives Greenlight to Allergan’s XEN® Registration for the Surgical Management of Refractory Glaucoma | PR Newswire | 4/2/2020

China Gives Greenlight to Allergan’s XEN® Registration for the Surgical Management of Refractory Glaucoma News provided by Apr 02, 2020, 07:30 ET Share this article – XEN ® Becomes the First Medical Product Approved by Using Real World Evidence in China – DUBLIN , April 2, 2020 /PRNewswire/ – Allergan plc (NYSE: AGN ) today announced China’s National Medical Products Administration (NMPA) approved the registration of Allergan’s XEN ® Gel Stent on March 26, 2020 for the …

AbbVie

AbbVie UK Announces Collaboration With NorthWest EHealth to Generate Real World Evidence to Drive Improvements in Patient Care | 11/27/2019

AbbVie UK Announces Collaboration With NorthWest EHealth to Generate Real World Evidence to Drive Improvements in Patient Care (Ref: AbbVie) AbbVie and NorthWest EHealth intend to explore the underlying associations between autoimmune conditions, using technology to interrogate data from NHS general practices Greater Manchester’s population makes the region the ideal location to conduct the work This project is an example of the partnership approach envisaged by the UK Government’s Life …

Eli Lilly

Comparison Of Methods To Estimate Disease-Related Cost And Healthcare Resource Utilization For Autoimmune Diseases In Administrative Claims Databases | 11/26/2019

Dr Justinn Cochran 2 Professor Giorgio Lorenzo Colombo Krista M Schroeder, 1 Steve Gelwicks, 1 April N Naegeli, 1 Pamela C Heaton 2 1 Global Patient Outcomes – Real World Evidence, Eli Lilly and Company, Indianapolis, IN, USA; 2 James L. Winkle College of Pharmacy, University of Cincinnati Academic Health Center, Cincinnati, OH, USACorrespondence: Krista M SchroederEli Lilly and Company, Indianapolis, IN 46285, USATel +1 317 276 3039Email schroeder_krista_marie …

Johnson & Johnson

Janssen Leverages Wearable Technology to Reimagine Clinical Trial Design | PR Newswire | 11/16/2019

TITUSVILLE, N.J. , Nov. 16, 2019 /PRNewswire/ – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the launch of the next evolution of digital clinical trial design with CHIEF-HF, the first-ever completely decentralized, mobile, indication-seeking clinical study. To accelerate the study and fast-track results, all contact with participants will be done virtually, with no in-person clinical visits required. Drawing on previous experience, the Company is utilizing …

Bristol-Myers

Medidata NEXT NYC 2019 Delivers Roadmap for Future Innovation in Clinical Research | Business Wire | 11/14/2019

… PPD. This honors customers who are leading the way to improve lives through technology by demonstrating a commitment to decreasing burden to trial participants with a patient-first approach. Data Insights & Innovation Award: Bristol-Myers Squibb. This showcases a customer who has utilized data insights to improve decision making and drive innovation across clinical development and launch readiness. Partnership of the Year: ICON Medical Imaging. The award recognizes a partnership …

Pfizer

Johnson & Johnson’s Blasine Penkowski Elected National Pharmaceutical Council Board Chair | PR Newswire | 11/13/2019

… Real World Evidence, Eli Lilly and Company (At-large) Justin McCarthy , JD, Senior Vice President, Patient and Health Impact, Pfizer Inc. (At-large) In addition to the executive committee, the Board of Directors made appointments to two standing Board-level committees. Jan Hansen , PhD, Vice President, Evidence for Access Medical Unit, U.S. Medical Affairs, Genentech, Inc., will serve as chair of the Board-level Research Committee, and Christine Marsh , MBA …

Boehringer Ingelheim

Johnson & Johnson’s Blasine Penkowski Elected National Pharmaceutical Council Board Chair | PR Newswire | 11/13/2019

… Executive Vice President and Chief Scientific Officer, Mallinckrodt Pharmaceuticals (Treasurer) Mark J. Nagy , MBA, Vice President, Global Patient Outcomes and Real World Evidence, Eli Lilly and Company (At-large) Justin McCarthy , JD, Senior Vice President … Committee, and Christine Marsh , MBA, Senior Vice President, Market Access, Boehringer Ingelheim Pharmaceuticals, Inc., will serve a second term as chair of the Strategic Advisory Group. These committees provide input to the Board on research …

Bristol-Myers Squibb

Johnson & Johnson’s Blasine Penkowski Elected National Pharmaceutical Council Board Chair | PR Newswire | 11/13/2019

Bristol-Myers Squibb (Vice Chair) Steven J. Romano , MD, Executive Vice President and Chief Scientific Officer, Mallinckrodt Pharmaceuticals (Treasurer) Mark J. Nagy , MBA, Vice President, Global Patient Outcomes and Real World Evidence, Eli Lilly and Company (At-large) Justin McCarthy , JD, Senior Vice President, Patient and Health Impact, Pfizer Inc. (At-large) In addition to the executive committee, the Board of Directors made appointments to two standing Board-level committees …

Medidata

Infographic: The State of Real World Evidence | 11/9/2019

Industry Insights Industry Insights Infographic: The State of Real World Evidence SHYFT Analytics, a Medidata company, is the leading platform for commercial and real-world data analytics with products designed specifically for the pharmaceutical, biotech, and medical device industry. SHYFT’s data analytics platform is the most efficient and scalable way to transform massive amounts of complex healthcare data into on-demand clinical and commercial insight. SHYFT is headquartered in Boston …

Merck

Associate Principal Scientist, Economic & Data Sciences - West Point, PA, , USA #jobs #West Point pls RT | 11/6/2019

Job Detail for Associate Principal Scientist, Economic & Data Sciences Job Location: Merck, West Point, PA, , USA Job Detail for Associate Principal Scientist, Economic & Data Sciences Job Location: Merck, West Point, PA, , USA Jobs In Associate Principal Scientist… Jobs In Associate Prin… Jobs In Associate… Job Description Economic and Data Sciences is part of our Company’s Center for Observational and Real World Evidence (CORE) The Center for Observational and Real-world …

Optum

VC-backed Mindstrong Health appoints CEO | PE Hub | 11/1/2019

… Daniel Graf as CEO. Prior to joining Mindstrong, Graf led product at Uber . Mindstrong is backed by ARCH Venture Partners, Optum Ventures, General Catalyst, Foresite Capital, Bezos Expeditions, Decheng Capital, Berggruen Holdings and One Mind … health system for people with serious mental illness. By gathering real world evidence, we can create a digital health future based on deep science and state-of-the-art technology that can meet the patient …

Propeller Health

Digital health is growing fast — but at what cost? | TechCrunch | 7/10/2019

Share on Twitter Chris Hogg is a digital health advocate interested in how new forms of health data are changing the relationship between physician and patient. As CCO of Propeller Health , he leads the company’s San Francisco office and oversees the pharma BD, health system and payer sales, clinical and medical affairs and data science teams. Silicon Valley is obsessed with growth. And for digital health startups, that obsession is …

WellDoc

Digital health is growing fast — but at what cost? | TechCrunch | 7/10/2019

… days of digital health, I think we were much more focused on the patient than we are now. When I think of the early digital health companies — not just Propeller, but Omada Health, WellDoc, Ginger.io and Mango Health — all of their founders had an innate understanding of the importance of health outcomes. They craved proof that their product worked. They might have “faked it” a little bit when it came …

Omada Health

Digital health is growing fast — but at what cost? | TechCrunch | 7/10/2019

… the early days of digital health, I think we were much more focused on the patient than we are now. When I think of the early digital health companies — not just Propeller, but Omada Health, WellDoc, Ginger.io and Mango Health — all of their founders had an innate understanding of the importance of health outcomes. They craved proof that their product worked. They might have “faked it” a little bit when …

Flatiron Health

FDA Leverages Private Sector Technology Based Tools In Its Embrace Of Real World Evidence | Forbes | 7/9/2019

… label expansion and regulatory oversight tasks. The agency has signaled its apparent change of heart with speeches, policy guidance, and now with two public-private partnerships: the recent expansion of its agreement with Flatiron Health , and a brand new collaboration with COTA Healthcare . The Flatiron collaboration initially focused on patients being treated with immunotherapy for advanced non-small cell lung cancer; the new work concerns “the use of RWE in …

Navigant

IQVIA Launches eCOA Based Patient Centered Endpoints Solution - June 26, 2019 - Zacks.com | 6/26/2019

… IQVIA stated. “IQVIA is committed to bringing together deep scientific expertise and cutting-edge technology to disrupt clinical development and real world evidence generation”. We observe that shares of IQVIA have gained 32.7% year to … ranked stocks in the broader Zacks Business Services sector are Navigant Consulting ( NCI - Free Report ) , NV5 Global ( NVEE - Free Report ) and FLEETCOR Technologies ( FLT - Free Report ) . While Navigant Consulting sports a Zacks Rank 1 (Strong …

Biogen

Biosimilars: The Importance of Real-World Evidence (2019) Featuring Sandoz, Avalere, and Biogen - ResearchAndMarkets.com | Business Wire | 6/25/2019

… strategy, what evidence do they want and, more importantly, what data sources will deliver? In this new report, Biosimilars: The Importance of Real-World Evidence , experts from companies such as Sandoz, Avalere, and Biogen reveal their insights on the practical issues and challenges of cost-effectively generating powerful RWE that really drives physician understanding, increases patient confidence and positively influences wider stakeholders. Biosimilar Experts Tackle Key Questions What role does …

Goldman Sachs

Syneos Health, Inc. (SYNH) CEO Alistair Macdonald on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 11/3/2019

… Participants Sandy Draper - SunTrust Erin Wright - Credit Suisse David Windley - Jefferies Eric Coldwell - Baird Tycho Peterson - JP Morgan Robert Jones - Goldman Sachs John Kreger - William Blair Elizabeth Anderson - Evercore ISI Dan Brennan - UBS Stephen Baxter … to, whether it fails in clinical or it goes through Real World Evidence, et cetera, all the way through to commercialization. We’ll be engaged with this customer all the way along with that asset. So …

McKesson Corporation (MCK) CEO Brian Tyler on Q2 2020 Results - Earnings Call Transcript | Seeking Alpha | 10/30/2019

… Research LLC Michael Cherny - Bank of America Merrill Lynch Charles Rhyee - Cowen & Company Steven Valiquette - Barclays Bank PLC Robert Jones - Goldman Sachs & Co. Kevin Caliendo - UBS Operator Good day, and welcome to McKesson’s Q2 Earnings … and a suite of data services providing commercial insights and real world evidence. These services help ensure biopharma manufacturers are successful in the post-launch commercialization of their products. These three businesses are well-positioned …

William Blair

Syneos Health, Inc. (SYNH) CEO Alistair Macdonald on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 11/3/2019

… Erin Wright - Credit Suisse David Windley - Jefferies Eric Coldwell - Baird Tycho Peterson - JP Morgan Robert Jones - Goldman Sachs John Kreger - William Blair Elizabeth Anderson - Evercore ISI Dan Brennan - UBS Stephen Baxter - Wolfe Research Operator Good … to, whether it fails in clinical or it goes through Real World Evidence, et cetera, all the way through to commercialization. We’ll be engaged with this customer all the way along with that asset. So …

Exact Sciences Corporation (EXAS) CEO Kevin Conroy on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/1/2019

… Jeff Elliott - CFO Mark Stenhouse - President of Cologuard Conference Call Participants Patrick Donnelly - Goldman Sachs Brandon Couillard - Jefferies Brian Weinstein - William Blair Doug Schenkel - Cowen & Company Catherine Schulte - Robert W. Baird Dan Brennan - UBS Puneet … detection. In addition to our pipeline work, we will present real world evidence supporting continued Cologuard use for providers and guideline groups at DDW. One of the liquid biopsy tests we’re working on in collaboration …

Merrill Lynch

McKesson Corporation (MCK) CEO Brian Tyler on Q2 2020 Results - Earnings Call Transcript | Seeking Alpha | 10/30/2019

… Eric Percher - Nephron Research Lisa Gill - JPMorgan Brian Tanquilut - Jefferies Stephen Baxter - Wolfe Research LLC Michael Cherny - Bank of America Merrill Lynch Charles Rhyee - Cowen & Company Steven Valiquette - Barclays Bank PLC Robert Jones - Goldman Sachs … and a suite of data services providing commercial insights and real world evidence. These services help ensure biopharma manufacturers are successful in the post-launch commercialization of their products. These three businesses are well-positioned …

Allscripts Healthcare Solutions, Inc. (MDRX) CEO Paul Black on Q1 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/3/2019

… CEO Rick Poulton - President Dennis Olis - CFO Stephen Shulstein - VP of IR Conference Call Participants Michael Cherny - Bank of America Merrill Lynch Jamie Stockton - Wells Fargo Robert Jones - Goldman Sachs Charles Rhyee - Cowen & Company Richard … unique value in these end markets. We use our expansive real world evidence combined data set of more than 150 million unique patient records to provide advanced analytic solutions and insights focused on improving care …

Morgan Stanley

Eli Lilly and Company (LLY) Presents Webcast to Discuss ADA Presentations and Diabetes Portfolio Conference (Transcript) | Seeking Alpha | 6/10/2019

… Global Development Leader, Incretins Jeffrey Emmick - VP, Diabetes Product Development Louise Chen - Cantor Fitzgerald Chris Schott - JP Morgan David Risinger - Morgan Stanley Terence Flynn - Goldman Sachs Umer Raffat - Evercore Vamil Divan - Credit Suisse Seamus Fernandez … patients with type 2 diabetes from a broader perspective. The real world evidence or RWE study recently published in the journal diabetes, obesity and metabolism assess the proportion of U.S. patients with type 2 diabetes …

Haemonetics Corporation (HAE) CEO Chris Simon on Q4 2019 Results - Earnings Call Transcript | Seeking Alpha | 5/11/2019

… Participants Olga Vlasova – Investor Relations Chris Simon – Chief Executive Officer Bill burke – Chief Financial Officer Conference Call Participants David Lewis – Morgan Stanley Anthony Petrone – Jefferies Dave Turkaly – JMP Securities Larry Keusch – Raymond James Mike Petusky … positioned to support this industry growth. And we have compelling real world evidence that gives us confidence in our value proposition and our continued progress towards upgrading customers to the new system. Customers have now …

MD Anderson Cancer Center

FDA rotating commissioner’s chair finds new nominee, former national coordinator joins Google, and more digital health hires and departures | MobiHealthNews | 11/5/2019

… acting commissioner of the FDA, with President Donald Trump pointing to Dr. Stephen Hahn , currently the chief medical officer of MD Anderson Cancer Center, as his official appointment for the role on Friday. Assistant Secretary … united with a powerful multi-modal research tool that supports real world evidence collection,” Berlin said in a statement. “I am thrilled to join Backpack Health as the company continues innovating to support the evolving …

FDA’s rotating commissioner’s chair finds new nominee, former national coordinator joins Google, and more digital health hires and departures | MobiHealthNews | 11/5/2019

… acting commissioner of the FDA, with President Donald Trump pointing to Dr. Stephen Hahn , currently the chief medical officer of MD Anderson Cancer Center, as his official appointment for the role on Friday. Assistant Secretary … united with a powerful multi-modal research tool that supports real world evidence collection,” Berlin said in a statement. “I am thrilled to join Backpack Health as the company continues innovating to support the evolving …

Premier Health

Open Health to merge with Pharmerit International | PE Hub | 11/4/2019

… a broad therapeutic range has a strong focus on oncology, rare diseases and specialist medicines. For more information on OPEN Health, please visit www.openhealthgroup.com . About Pharmerit International, LP Pharmerit International is a global, premier health economics and outcomes research (HEOR) consultancy with 20 years of experience supporting pharmaceutical, biotechnology, and medical device organizations in health economics and outcomes research (HEOR) and market access worldwide. Pharmerit delivers quality research across four …

Amulet Capital’s OPEN Health Merges with Pharmerit International | Business Wire | 11/4/2019

… a broad therapeutic range has a strong focus on oncology, rare diseases and specialist medicines. For more information on OPEN Health, please visit www.openhealthgroup.com . About Pharmerit International, LP Pharmerit International is a global, premier health economics and outcomes research (HEOR) consultancy with 20 years of experience supporting pharmaceutical, biotechnology, and medical device organizations in health economics and outcomes research (HEOR) and market access worldwide. Pharmerit delivers quality research across four …

Mayo Clinic

Janssen Presenting Data From Its Expanding Rheumatology Portfolio At The 2019 Annual Meeting Of The American College Of Rheumatology | PR Newswire | 10/31/2019

… Form and Profile-29 T-Scores with SF-36 in Rheumatoid Arthritis Patients Treated for 1 year: Results from a Real World Evidence- Based Study in the United States Monday, November 11 9:00-11:00 am Others … at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958815/ . Accessed October 2017. 4 Mayo Clinic. Psoriatic Arthritis. Available at: http://www.mayoclinic.org/diseases-conditions/psoriatic-arthritis/home/ovc-20233896 . Accessed October 2017. 5 2017 Mease PJ, et al. J …

Janssen Presenting Data From Its Expanding Rheumatology Portfolio At The 2019 Annual Meeting Of The American College Of Rheumatology - The Delaware County Daily Times | 10/31/2019

… of PROMIS Short Formand Profile-29 T-Scores with SF-36 inRheumatoid Arthritis Patients Treated for 1year: Results from a Real World Evidence-Based Study in the United States Monday, November 11 Psychometric Evaluation of … at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958815/ . Accessed October 2017. 4 Mayo Clinic. Psoriatic Arthritis. Available at: http://www.mayoclinic.org/diseases-conditions/psoriatic-arthritis/home/ovc-20233896 . Accessed October 2017. 5 2017 Mease PJ, et al. J …

Sinai Health System

PM360 Announces NASHNET, pioneered by The Kinetix Group, as a Finalist for Its 2019 Trailblazer Award | PR Newswire | 8/27/2019

… are affected by NAFLD, with most patients undiagnosed,” says Douglas Dieterich , MD, Director of the Institute for Liver Medicine, Mount Sinai Health System. “ Given this high prevalence of disease, cost effective risk stratification strategies need … challenges across the NASH spectrum, including care coordination, population health, real world evidence, and clinical trials. NASHNET is powered by The Kinetix Group and headquartered in NYC. About The Kinetix Group The Kinetix Group empowers …

Univision Joins NASHNET in Advancing Awareness of NASH in Latino Populations | PR Newswire | 6/12/2019

… high-volume chronic condition. “An estimated 30 percent of individuals in the U.S. are affected by NAFLD, with most patients undiagnosed,” says Douglas Dieterich , MD, Director of the Institute for Liver Medicine, Mount Sinai Health System, and charter member of NASHNET. “Given this high prevalence of disease, cost effective risk stratification strategies need to be proven and adopted to target more effective assessments and interventions for those patients at greater …

Dana Farber Cancer Institute

Flatiron Health Appoints Cancer Researcher and Pharmaceutical Executive Dr. Michael Vasconcelles as Chief Medical Officer | Business Wire | 6/14/2019

Flatiron Health Appoints Cancer Researcher and Pharmaceutical Executive Dr. Michael Vasconcelles as Chief Medical Officer Jun 14, 2019 Save NEW YORK–(BUSINESS WIRE)–Jun 14, 2019– Flatiron Health today announced that Dr. Michael Vasconcelles, a practicing oncologist and senior biotechnology and pharmaceutical executive, has joined as Chief Medical Officer, effective August 2019. Dr. Vasconcelles will be responsible for defining and executing the company’s strategic vision for real-world evidence, providing …

WIN 2019 Symposium: WINnovation and Global Deployment of Precision Oncology | Business Wire | 5/17/2019

… will deliver breakthrough science, including: Prof. Jennifer A. Doudna, PhD, University of California, Berkeley, USA “ Rewriting the Code of Life: CRISPR-Cas Genome Editing”. Dr. Jennifer A. Ligibel, MD, Harvard Medical School and Dana Farber Cancer Institute, USA “ Lifestyle-based Prevention Strategies”. Dr. Razelle Kurzrock, MD, University of California, San Diego, USA, “ Innovation in Clinical Trials: WINTHER trial”, first study pioneered by the WIN Consortium ( ) , that showed that assessing RNA …

Harvard Medical School

Oncopeptides Announces Melflufen Data Accepted for Presentation at 2019 ASCO Annual Meeting | Markets Insider | Business Insider | 5/15/2019

… were treated with melflufen and dexamethasone in the Phase 1/2 clinical study named O-12-M1. TTNT is used in Real World Evidence to assist treatment decisions and support economic reimbursement modeling. “The acceptance of … RRMM). Presenter: Paul G. Richardson , MD, Dana-Farber Cancer Institute, Harvard Medical School , Boston, MA Session: Hematologic Malignancies—Plasma Cell Dyscrasia Date/Time: Monday, June 3 , 8:00-11:00 a.m. Central Location: Hall A (Poster 369) Abstract …

Oncopeptides Announces Melflufen Data Accepted for Presentation at 2019 ASCO Annual Meeting | Markets Insider | Business Insider | 5/15/2019

… were treated with melflufen and dexamethasone in the Phase 1/2 clinical study named O-12-M1. TTNT is used in Real World Evidence to assist treatment decisions and support economic reimbursement modeling. “The acceptance of … RRMM). Presenter: Paul G. Richardson , MD, Dana-Farber Cancer Institute, Harvard Medical School , Boston, MA Session: Hematologic Malignancies—Plasma Cell Dyscrasia Date/Time: Monday, June 3 , 8:00-11:00 a.m. Central Location: Hall A (Poster 369) Abstract …

Ian Rentsch

Trialbee Partners with Clinerion for Expanded Access to Global Real-World Data to Accelerate Patient Recruitment for Clinical Trials | PRWeb | 8/25/2020

… strategies. “Patients are at the center of everything Clinerion does, and this partnership will ensure better outcomes for patients,” says Ian Rentsch, CEO of Clinerion. “Together, we will be able to match more of the … world data from our global network of partner hospitals for Real World Evidence analyses. Clinerion’s Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site …

Don Rucker

NCCN Policy Summit Explores 21st Century Cures Act and the Impact of Health Information Technology | Yahoo News | 6/10/2020

real world evidence is changing the research landscape. Don Rucker , MD, MBA, MS , National Coordinator for Health Information Technology , Office of the National Coordinator for Health IT (ONC) spoke about increasing the use of electronic medical records. NCCN Logo (C)NCCN(R) 2018. All rights reserved. Más “The Office of the National Coordinator for Health Information Technology’s 21 st Century Cures Act Final Rule will give patients unprecedented access and …

Clifford Goodman

NCCN Policy Summit Explores 21st Century Cures Act and the Impact of Health Information Technology | Yahoo News | 6/10/2020

… of Food and Drugs , The Food and Drug Administration (FDA) held a fireside chat on clinical trials, data, and how real world evidence is changing the research landscape. Don Rucker , MD, MBA, MS , National Coordinator … also a key theme for the panel discussion moderated by Clifford Goodman , PhD, Senior Vice President of The Lewin Group and featuring Jenny Ahlstrom , Founder , CrowdCare Foundation and Multiple Myeloma Patient; Clay Alspach , JD , Principa …

Carolyn Magill

Aetion and HealthVerity Launch Integrated Real-World Evidence Solution to Assess the Safety and Effectiveness of COVID-19 Interventions | PR Newswire | 4/22/2020

… overall and how patients, infected or not, are accessing health care resources. “As the industry moves to accelerate interventions for the treatment and prevention of COVID-19, the stakes are incredibly high,” said Carolyn Magill , CEO of Aetion. “Our offerings use HealthVerity’s comprehensive, real-time data to obtain decision-ready insights that can help meet the need for accelerated approvals and access, while maintaining our high bar for evidence to …

Kevin Lust

Scientist.com and HealthEconomics.Com Partner to Enable Online Sourcing of Health Economics and Outcomes Research (HEOR) and Real World Evidence (RWE) | Business Wire | 4/9/2020

Scientist.com and HealthEconomics.Com Partner to Enable Online Sourcing of Health Economics and Outcomes Research (HEOR) and Real World Evidence (RWE) The HEOR & RWE Marketplace connects buyers and sellers of HEOR and RWE April 09, 2020 … research projects while sequestered during the Covid-19 pandemic,” stated Kevin Lustig, Ph.D., CEO and Founder of Scientist.com. “Partnering with HealthEconomics.Com to create a virtual marketplace for HEOR and RWE will allow critical research to …

Kevin Lustig

Scientist.com and HealthEconomics.Com Partner to Enable Online Sourcing of Health Economics and Outcomes Research (HEOR) and Real World Evidence (RWE) | Business Wire | 4/9/2020

Scientist.com and HealthEconomics.Com Partner to Enable Online Sourcing of Health Economics and Outcomes Research (HEOR) and Real World Evidence (RWE) The HEOR & RWE Marketplace connects buyers and sellers of HEOR and RWE April 09, 2020 … research projects while sequestered during the Covid-19 pandemic,” stated Kevin Lustig, Ph.D., CEO and Founder of Scientist.com. “Partnering with HealthEconomics.Com to create a virtual marketplace for HEOR and RWE will allow critical research to …

Laura Wood

Global Real-World Evidence (RWE) Solutions Market Study 2019-2024 - Oncology Anticipated to Be the Dominant Segment | PR Newswire | 11/29/2019

… AND FUTURE TRENDS For more information about this report visit https://www.researchandmarkets.com/r/7axovt Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood , Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 SOURCE Research and Markets Related …

Anirban Choudhury

Quantzig Offers Advanced HR Analytics Solutions to Help Businesses Enhance Workforce Performance Through Data-driven Decision Making | Request a FREE Demo | Business Wire | 11/14/2019

… development, and retention. Talk to our analytics experts about how we can provide tailored HR analytics solutions for you. Quantzig’s Real World Evidence Analytics Solutions Employee Attrition Modeling Employee Performance Analytics Employee Acquisition Analytics Our … pricing plans, visit: https://www.quantzig.com/request-for-proposal Contacts Quantzig Anirban Choudhury Marketing Manager US: +1 630 538 7144 UK: +44 208 629 1455 https://www.quantzig.com/contact-us …

Mark J. Nagy

Johnson & Johnson’s Blasine Penkowski Elected National Pharmaceutical Council Board Chair | PR Newswire | 11/13/2019

Mark J. Nagy , MBA, Vice President, Global Patient Outcomes and Real World Evidence, Eli Lilly and Company (At-large) Justin McCarthy , JD, Senior Vice President, Patient and Health Impact, Pfizer Inc. (At-large) In addition to the executive committee, the Board of Directors made appointments to two standing Board-level committees. Jan Hansen , PhD, Vice President, Evidence for Access Medical Unit, U.S. Medical Affairs, Genentech, Inc., will serve as chair …

Dan Leonard

Johnson & Johnson’s Blasine Penkowski Elected National Pharmaceutical Council Board Chair | PR Newswire | 11/13/2019

… efforts to bring smart health policy research and analysis to these pressing discussions,” said NPC President and Chief Executive Officer Dan Leonard . “As health spending and value top the national health care agenda, we’re excited … Mark J. Nagy , MBA, Vice President, Global Patient Outcomes and Real World Evidence, Eli Lilly and Company (At-large) Justin McCarthy , JD, Senior Vice President, Patient and Health Impact, Pfizer Inc. (At-large) In addition …

Robert Jones

Syneos Health, Inc. (SYNH) CEO Alistair Macdonald on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 11/3/2019

… Conference Call Participants Sandy Draper - SunTrust Erin Wright - Credit Suisse David Windley - Jefferies Eric Coldwell - Baird Tycho Peterson - JP Morgan Robert Jones - Goldman Sachs John Kreger - William Blair Elizabeth Anderson - Evercore ISI Dan Brennan - UBS … to, whether it fails in clinical or it goes through Real World Evidence, et cetera, all the way through to commercialization. We’ll be engaged with this customer all the way along with that asset. So …

David Van Sickle

Digital health is growing fast — but at what cost? | TechCrunch | 7/10/2019

… thought things would happen faster than they have — but when it came to research, they had answers, or a concrete plan to get answers. My first conversation with Propeller’s co-founder and CEO, David Van Sickle, was illustrative of this. I met David at the geekiest of health conferences, Health Datapalooza. We talked about how sensors on medicines could improve people’s health. We talked about study designs and methods to …